We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$144B
AUM Growth
+$2.8B
(+2%)
Cap. Flow
-$5.9B
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
347
New
10
Increased
58
Reduced
237
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$187M |
| 2 |
Intel
INTC
|
+$174M |
| 3 |
Aurora
AUR
|
+$114M |
| 4 |
Alibaba
BABA
|
+$86.2M |
| 5 |
Pulmonx
LUNG
|
+$72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$763M |
| 2 |
Tesla
TSLA
|
+$478M |
| 3 |
Adobe
ADBE
|
+$327M |
| 4 |
Microsoft
MSFT
|
+$319M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Healthcare | 26% |
| 3 | Industrials | 11.45% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Financials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Morgan Stanley
MS
$340B
| $864M | 0.6% |
8,802,831
-1,011,204
| -10% | -$101M |
|
52
Elanco Animal Health
ELAN
$11.1B
| $856M | 0.59% |
30,158,966
-593,979
| -2% | -$18.5M |
|
53
Oracle
ORCL
$423B
| $851M | 0.59% |
9,752,370
-199,930
| -2% | -$18.8M |
|
54
Visa
V
$677B
| $849M | 0.59% |
3,919,539
+189,200
| +5% | +$40.6M |
|
55
Analog Devices
ADI
$190B
| $786M | 0.54% |
4,473,170
-38,940
| -0.9% | -$6.9M |
|
56
Delta Air Lines
DAL
$60.1B
| $767M | 0.53% |
19,631,738
-1,231,170
| -6% | -$49.3M |
|
57
Abbott
ABT
$187B
| $756M | 0.52% |
5,370,433
-430,140
| -7% | -$55.1M |
|
58
Union Pacific
UNP
$174B
| $746M | 0.52% |
2,962,412
-100,700
| -3% | -$23.9M |
|
59
American Airlines Group
AAL
$10.6B
| $735M | 0.51% |
40,897,051
-1,701,885
| -4% | -$32.6M |
|
|
SGEN
60
DELISTED
Seagen Inc. Common Stock
SGEN
| $718M | 0.5% |
4,647,090
-188,810
| -4% | -$31.6M |
|
|
HES
61
DELISTED
Hess
HES
| $699M | 0.48% |
9,437,505
-42,370
| -0.4% | -$3.44M |
|
62
Caterpillar
CAT
$387B
| $698M | 0.48% |
3,377,908
-137,350
| -4% | -$27.7M |
|
63
Applied Materials
AMAT
$428B
| $685M | 0.47% |
4,355,583
-188,900
| -4% | -$27.4M |
|
64
ASML
ASML
$669B
| $621M | 0.43% |
779,679
-45,100
| -5% | -$35.8M |
|
65
Albemarle
ALB
$15.5B
| $619M | 0.43% |
2,646,105
-217,540
| -8% | -$53.8M |
|
|
ABMD
66
DELISTED
Abiomed Inc
ABMD
| $599M | 0.41% |
1,667,632
-132,860
| -7% | -$44.9M |
|
67
United Parcel Service
UPS
$88.9B
| $598M | 0.41% |
2,791,591
-235,600
| -8% | -$47.9M |
|
68
Walt Disney
DIS
$181B
| $536M | 0.37% |
3,458,667
-168,390
| -5% | -$27.2M |
|
69
Zimmer Biomet
ZBH
$18.4B
| $517M | 0.36% |
4,190,679
+196,432
| +5% | +$25.7M |
|
70
Trimble
TRMB
$13.9B
| $500M | 0.35% |
5,732,981
-349,359
| -6% | -$30M |
|
71
Cisco
CSCO
$479B
| $493M | 0.34% |
7,786,990
-1,045,900
| -12% | -$59.8M |
|
72
Northern Trust
NTRS
$33.9B
| $481M | 0.33% |
4,017,342
+90,505
| +2% | +$10.8M |
|
73
PayPal
PYPL
$50.5B
| $459M | 0.32% |
2,436,400
-87,650
| -3% | -$19M |
|
74
Textron
TXT
$15.4B
| $456M | 0.32% |
5,912,130
-86,060
| -1% | -$6.39M |
|
75
CVS Health
CVS
$122B
| $440M | 0.3% |
4,263,235
-70,960
| -2% | -$6.56M |
|
Similar funds
VAM
Primecap Management's Q4 2021 Portfolio in Review
As of Q4 2021, Primecap Management held 347 positions worth $144B, up 2% from $142B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management withdrew a net $5.9B in Q4 2021, closing 5 positions and reducing 237 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $10M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Aurora worth $116M.
- Primecap Management's largest Q4 2021 buy was Aurora: 10,279,870 shares worth $116M.
- Primecap Management added most to Bristol-Myers Squibb in Q4 2021, an estimated $187M increase.
- Primecap Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $763M.
- Primecap Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $10M.
- Primecap Management's ten largest holdings make up 30% of its $144B portfolio in Q4 2021.
- Primecap Management opened 10 new positions and closed 5 in Q4 2021.
- Primecap Management's portfolio value rose 2% quarter-over-quarter to $144B.
Based on Primecap Management's 13F filing for Q4 2021, filed 11 Feb 2022.